| (2Z,5Z)-5-(3-chloro-4-((R)-2,3-dihydroxypropoxy)benzylidene)-2-(propyliMino)-3-(o-tolyl)thiazolidin-4-one |
PONESIMOD |
854107-55-4 |
| ReModelin hydrobroMide |
REMODELIN |
1622921-15-6 |
| Sitagliptin |
西他列汀 |
486460-32-6 |
| Tofacitinib citrate |
枸橼酸托法替尼 |
540737-29-9 |
| SANT-1 |
SANT1 |
304909-07-7 |
| m-tolyl 5-chloro-2-(ethylsulfonyl)pyrimidine-4-carboxylate |
SBI-115; SBI 115; SBI115 |
882366-16-7 |
| Cefiderocol |
头孢地尔 |
1225208-94-5 |
| CL2A-SN-38 |
CL2A-SN-38 |
1279680-68-0 |
| BenzaMide, 4-[(4-Methyl-1-piperazinyl)Methyl]-N-[6-Methyl-5-[[4-(3-pyridinyl)-2-pyriMidinyl]aMino]-3-pyridinyl]-3-(trifluoroMethyl)-, MonoMethanesulfonate (9CI) |
甲磺酸氟马替尼/氟马替尼 |
895519-91-2 |
| 4-((N-benzyl-8-chloro-1-methyl-1,4-dihydrochromeno[4,3-c]pyrazole-3-carboxamido)methyl)benzoicacid |
NIDUFEXOR |
1773489-72-7 |
| Verinurad |
维立诺雷 |
1352792-74-5 |
| pilaralisib |
2-氨基-N-[3-[N-[3-[(2-氯-5-甲氧基苯基)氨基]喹喔啉-2-基]氨基磺酰基]苯基]-2-甲基丙酰胺 |
934526-89-3 |
| SP2509 |
无中文名称 |
1423715-09-6 |
| Enasidenib |
恩西地平 |
1446502-11-9 |
| ABBV-075 |
米维布塞 |
1445993-26-9 |
| GSK-2110183C |
GSK-2110183C |
1047644-62-1 |
| Velpatasvir |
维帕他韦 |
1377049-84-7 |
| Encorafenib (LGX818) |
康奈非尼 |
1269440-17-6 |
| Ozanimod |
奥扎莫德 |
1306760-87-1 |
| LOXO-292 |
塞卡替尼 |
2152628-33-4 |
